Organometallics
Article
[(C6F5)3PF]+[B(C6F5)4]− (6; 3.1 mg, 2.5 μmol, 3.0 mol %) according
to GP1. The product 11a (20.6 mg, 71.0 μmol, 87%) was obtained as
a white solid after purification by flash column chromatography on
silica gel using cyclohexane/dichloromethane (100/0 → 80/20) as
eluent. Rf = 0.47 (cyclohexane/dichloromethane = 1/1). Mp: 118 °C
cyclohexane/dichloromethane (100/0 → 80/20) as eluent. Rf = 0.53
(cyclohexane/dichloromethane = 1/1). GLC (HP-5): tR = 30.9 min.
IR (ATR): ν
̃
2925 (w), 2859 (w), 1681 (s), 1229 (w), 1100 (m), 802
(m), 777 (s), 750 (m), 698 (s) cm−1. HRMS (APCI, m/z): calculated
for C25H23O+ [M + H]+, 339.1743; found, 339.1738. H NMR (500
1
MHz, CDCl3): δ 1.04−1.12 (m, 1H), 1.38−1.45 (m, 1H), 1.75−1.82
(m, 2H), 2.65−2.66 (m, 1H), 2.92−2.93 (m, 1H), 3.55−3.56 (m,
1H), 3.76−3.78 (m, 1H), 6.17−6.21 (m, 1H), 6.60−6.64 (m, 1H),
7.21−7.25 (m, 1H), 7.28−7.38 (m, 5H), 7.51−7.53 (m, 3H), 7.85−
7.87 (m, 1H), 7.89 (d, J = 8.3 Hz, 1H), 8.10−8.12 (m, 1H). 13C{1H}
NMR (126 MHz, CDCl3): δ 18.8, 26.4, 33.8, 37.0, 44.4, 55.3, 124.4,
125.5, 125.6, 126.3, 126.5, 127.5, 128.3 (2C), 128.5, 128.6 (2C),
130.6, 131.0, 131.3, 133.9, 137.0, 137.7, 143.0, 205.5. The analytical
and spectroscopic data are in accordance with those reported.27
endo-1-(3-Phenylbicyclo[2.2.2]oct-5-en-2-yl)ethan-1-one (11f).
Prepared from (E)-4-phenylbut-3-en-2-one (9f; 12 mg, 82 μmol,
1.0 equiv), cyclohexa-1,3-diene (10; 39 mg, 0.49 mmol, 6.0 equiv),
and [(C6F5)3PF]+[B(C6F5)4]− (6; 3.1 mg, 2.5 μmol, 3.0 mol %)
according to GP1. The product 11f (18.2 mg, 80.0 μmol, 98%) was
obtained as a yellow oil after purification by flash column
chromatography on silica gel using cyclohexane/dichloromethane
(100/0 → 2/1) as eluent. Rf = 0.37 (cyclohexane/dichloromethane =
(n-pentane). GLC (HP-5): tR = 24.4 min. IR (ATR): ν 2926 (w),
̃
2863 (w), 1672 (s), 1595 (w), 1446 (m), 1216 (m), 960 (m), 746
(s), 689 (s) cm−1. HRMS (APCI, m/z): calculated for C21H21O+ [M
1
+ H]+, 289.1587; found, 289.1582. H NMR (500 MHz, CDCl3): δ
1.10−1.16 (m, 1H), 1.46−1.52 (m, 1H), 1.81−1.86 (m, 1H), 1.88−
1.94 (m, 1H), 2.67−2.68 (m, 1H), 2.97−2.99 (m, 1H), 3.48−3.49
(m, 1H), 3.80−3.82 (m, 1H), 6.11−6.13 (m, 1H), 6.56−6.59 (m,
1H), 7.19−7.23 (m, 1H), 7.29−7.34 (m, 4H), 7.38−7.41 (m, 2H),
7.49−7.53 (m, 1H), 7.86−7.88 (m, 2H). 13C{1H} NMR (126 MHz,
CDCl3): δ 18.7, 26.6, 34.7, 36.6, 44.9, 51.1, 126.3, 128.3 (2C), 128.6
(4C), 128.6 (2C), 130.8, 132.8, 136.4, 136.6, 143.0, 200.9. The
analytical and spectroscopic data are in accordance with those
reported.27
endo-(2-Methoxyphenyl)(3-phenylbicyclo[2.2.2]oct-5-en-2-yl)-
methanone (11b). Prepared from (E)-1-(2-methoxyphenyl)-3-
phenylprop-2-en-1-one (9b; 19.5 mg, 82.0 μmol, 1.00 equiv),
cyclohexa-1,3-diene (10; 39 mg, 0.49 mmol, 6.0 equiv), and
[(C6F5)3PF]+[B(C6F5)4]− (6; 3.1 mg, 2.5 μmol, 3.0 mol %) according
to GP1. The product 11b (22.8 mg, 72.0 μmol, 88%) was obtained as
a colorless oil after purification by flash column chromatography on
silica gel using cyclohexane/dichloromethane (100/0 → 80/20 →
50/50) as eluent. Rf = 0.26 (cyclohexane/dichloromethane = 1/1).
1/1). GLC (HP-5): tR = 18.6 min. IR (ATR): ν 2941 (w), 2866 (w),
̃
1704 (s), 1353 (m), 1163 (m), 748 (m), 700 (s), 667 (m) cm−1.
HRMS (APCI, m/z): calculated for C16H19O+ [M + H]+, 227.1430;
1
found, 227.1426. H NMR (500 MHz, CDCl3): δ 1.00−1.06 (m,
1H), 1.43−1.48 (m, 1H), 1.65−1.76 (m, 2H), 2.03 (s, 3H), 2.52−
2.54 (m, 1H), 2.93−2.94 (m, 1H), 3.01−3.02 (m, 1H), 3.12−3.13
(m, 1H), 6.20−6.23 (m,1H), 6.46−6.49 (m, 1H), 7.22−7.25 (m,
1H), 7.28−7.29 (m, 2H), 7.33−7.36 (m, 2H). 13C{1H} NMR (126
MHz, CDCl3): δ 18.5, 26.1, 28.5, 32.7, 37.3, 45.6, 56.6, 126.5, 128.2
(2C), 128.6 (2C), 131.6, 136.1, 142.8, 209.0. The analytical and
spectroscopic data are in accordance with those reported.27
GLC (HP-5): tR = 25.9 min. IR (ATR): ν 2938 (w), 2863 (w), 1672
̃
(m), 1595 (m), 1483 (m), 1460 (m), 1434 (m), 1282 (m), 1242 (s),
1019 (m), 961 (m), 750 (s), 699 (s) cm−1. HRMS (APCI, m/z):
+
1
calculated for C22H23O2 [M + H]+, 319.1693; found, 319.1686. H
NMR (500 MHz, CDCl3): δ 1.03−1.09 (m, 1H), 1.40−1.45 (m, 1H),
1.71−1.80 (m, 2H), 2.60−2.61 (m, 1H), 2.96−2.97 (m, 1H), 3.40−
3.42 (m, 1H), 3.70 (s, 3H), 3.90−3.91 (m, 1H), 6.11−6.14 (m, 1H),
6.52−6.55 (m, 1H), 6.83 (d, J = 8.3 Hz, 1H), 6.95−6.97 (m, 1H),
7.17−7.20 (m, 1H), 7.25−7.32 (m, 4H), 7.35−7.39 (m, 1H), 7.43
(dd, J = 7.6 Hz, J = 1.7 Hz, 1H). 13C{1H} NMR (126 MHz, CDCl3):
δ 18.7, 26.5, 33.5, 37.0, 44.8, 55.0, 55.4, 111.3, 120.8, 126.0, 128.3
(2C), 128.3 (2C), 129.3, 130.1, 131.3, 132.4, 136.6, 143.4, 157.4,
204.5. The analytical and spectroscopic data are in accordance with
those reported.27
endo-Tricyclo[5.2.2.02,6]undec-8-en-3-one (11g). Prepared from
cyclopent-2-en-1-one (9g; 13 mg, 0.16 mmol, 1.0 equiv), cyclohexa-
1,3-diene (10; 78 mg, 0.97 mmol, 6.0 equiv), and [(C6F5)3PF]+[B-
(C6F5)4]− (6; 6.2 mg, 5.0 μmol, 3.0 mol %) according to GP1. The
product 11g (16.8 mg, 0.100 mmol, 63%) was obtained as a yellow oil
after purification by flash column chromatography on silica gel using
n-pentane/ethyl acetate (40/1) as eluent. Rf = 0.27 (cyclohexane/
ethyl acetate = 20/1). GLC (HP-5): tR = 13.0 min. IR (ATR): ν 2931
̃
(w), 2865 (w), 1726 (s), 1167 (m), 708 (s) cm−1. HRMS (APCI, m/
z): calculated for C11H15O+ [M + H]+, 163.1117; found, 163.1115.
1H NMR (500 MHz, CDCl3): δ 1.22−1.30 (m, 2H), 1.46−1.59 (m,
3H), 1.94−2.12 (m, 3H), 2.35−2.38 (mc, 1H), 2.52−2.58 (m, 1H),
2.64−2.65 (m, 1H), 2.93−2.95 (m, 1H), 6.14−6.17 (m, 1H), 6.20−
6.23 (m, 1H). 13C{1H} NMR (126 MHz, CDCl3): δ 24.2, 24.9, 26.2,
32.6, 35.6, 38.3, 39.8, 52.5, 133.7, 133.9, 222.9. The analytical and
spectroscopic data are in accordance with those reported.11
endo-Naphthalen-2-yl(3-phenylbicyclo[2.2.2]oct-5-en-2-yl)-
methanone (11d). Prepared from (E)-1-(naphthalen-2-yl)-3-phenyl-
prop-2-en-1-one (9d; 21 mg, 82 μmol, 1.0 equiv), cyclohexa-1,3-diene
(10; 39 mg, 0.49 mmol, 6.0 equiv), and [(C6F5)3PF]+[B(C6F5)4]− (6;
3.1 mg, 2.5 μmol, 3.0 mol %) according to GP1. The product 11d
(24.9 mg, 74.0 μmol, 90%) was obtained as a yellow solid after
purification by flash column chromatography on silica gel using
cyclohexane/dichloromethane (100/0 → 80/20) as eluent. Rf = 0.53
(cyclohexane/dichloromethane = 1/1). Mp: 151 °C (n-pentane).
endo-Tricyclo[6.2.2.02,7]dodec-9-en-3-one (11h). Prepared from
cyclohex-2-en-1-one (9h; 15 mg, 0.16 mmol, 1.0 equiv), cyclohexa-
1,3-diene (10; 77 mg, 0.96 mmol, 6.0 equiv), and [(C6F5)3PF]+[B-
(C6F5)4]− (6; 5.9 mg, 4.8 μmol, 3.0 mol %) according to GP1. The
product 11h (20.2 mg, 0.110 mmol, 69%) was obtained as a yellow oil
after purification by flash column chromatography on silica gel using
n-pentane/ethyl acetate (40/1) as eluent. Rf = 0.28 (cyclohexane/
GLC (HP-5): tR = 33.0 min. IR (ATR): ν 2926 (w), 2863 (w), 1671
̃
(s), 1451 (w), 1184 (w), 829 (m), 745 (s), 696 (s) cm−1. HRMS
(APCI, m/z): calculated for C25H23O+ [M + H]+, 339.1743; found,
339.1739. 1H NMR (500 MHz, CDCl3): δ 1.13−1.20 (m, 1H), 1.50−
1.57 (m, 1H), 1.86−1.92 (m, 1H), 1.94−1.99 (m, 1H), 2.68−2.70
(m, 1H), 3.06−3.08 (m, 1H), 3.45 (mc, 1H), 3.94 (mc, 1H), 6.22 (mc,
1H), 6.57 (mc, 1H), 7.23−7.25 (m, 1H), 7.33−7.35 (m, 4H), 7.49
(mc, 1H), 7.57 (mc, 1H), 7.74 (d, J = 8.2 Hz, 1H), 7.84 (d, J = 8.6 Hz,
2H), 7.97 (dd, J = 8.6 Hz, J = 1.7 Hz, 1H), 8.25 (s, 1H). 13C{1H}
NMR (126 MHz, CDCl3): δ 18.8, 26.4, 34.5, 36.7, 45.5, 51.7, 124.6,
126.4, 126.7, 127.8, 128.4 (4C), 128.7 (2C), 129.6, 130.2, 131.5,
132.6, 133.7, 135.5, 136.0, 143.2, 201.0. The analytical and
spectroscopic data are in accordance with those reported.27
ethyl acetate = 20/1); GLC (HP-5): tR = 14.6 min. IR (ATR): ν 2931
̃
(m), 2866 (w), 1700 (s), 713 (m) cm−1. HRMS (APCI, m/z):
1
calculated for C12H17O+ [M + H]+, 177.1274; found, 177.1269. H
NMR (500 MHz, CDCl3): δ 0.91−0.99 (m, 1H), 1.25−1.32 (m, 2H),
1.48−1.52 (m, 1H), 1.55−1.59 (m, 1H), 1.69−1.82 (m, 3H), 2.03−
2.11 (m, 1H), 2.32−2.35 (m, 1H), 2.36−2.41 (m, 1H), 2.42−2.44
(m, 1H), 2.50 (mc, 1H), 3.08 (mc, 1H), 6.12 (mc, 1H), 6.25 (mc, 1H).
13C{1H} NMR (126 MHz, CDCl3): δ 20.9, 24.1, 26.1, 29.7, 31.3,
endo-Naphthalen-1-yl(3-phenylbicyclo[2.2.2]oct-5-en-2-yl)-
methanone (11e). Prepared from (E)-1-(naphthalen-1-yl)-3-phenyl-
prop-2-en-1-one (9e; 21 mg, 82 μmol, 1.0 equiv), cyclohexa-1,3-diene
(10; 39 mg, 0.49 mmol, 6.0 equiv), and [(C6F5)3PF]+[B(C6F5)4]− (6;
3.1 mg, 2.5 μmol, 3.0 mol %) according to GP1. The product 11e
(14.2 mg, 42.0 μmol, 51%) was obtained as a yellow oil after
purification by flash column chromatography on silica gel using
36.0, 38.9, 42.3, 53.1, 133.2, 134.6, 214.6. The analytical and
spectroscopic data are in accordance with those reported.11
(3,4-Dimethyl-6-phenylcyclohex-3-en-1-yl)phenylmethanone
(20a). Prepared from (E)-chalcone (9a; 17 mg, 82 μmol, 1.0 equiv),
2,3-dimethylbuta-1,3-diene (19; 40 mg, 0.49 mmol, 6.0 equiv), and
[(C6F5)3PF]+[B(C6F5)4]− (6; 3.1 mg, 2.5 μmol, 3.0 mol %) according
E
Organometallics XXXX, XXX, XXX−XXX